RANOLAZINE (RANOLAZINE) — FDA Approval ANDA213517 (I3 PHARMS)
RANOLAZINE (RANOLAZINE) — FDA Approval ANDA213517 (I3 PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RANOLAZINE; Active ingredients: RANOLAZINE; Application number: ANDA213517.
| Brand name | RANOLAZINE |
|---|---|
| Active ingredients | RANOLAZINE |
| Application number | ANDA213517 |
| Sponsor | I3 PHARMS |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20220427 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →